Lyposomal amphotericine b in the treatment of systemic fungal infection in the neonate. The results of one case;La anfotericina B liposomal (AmBisome) en el tratamiento de las infecciones fungicas sistemicas en el neonato. A proposito de un caso

Anales Espanoles de Pediatria

Volumn 45, Issue 2, 1996, Pages 209-212

  Baquero Artigao, F ^a   Salas Hernandez S ^a   Quero Jimenez J ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; LIPOSOME;

ARTICLE; CANDIDA PARAPSILOSIS; CASE REPORT; DRUG FORMULATION; FEMALE; HUMAN; MYCOSIS; NEWBORN; NEWBORN INFECTION;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CANDIDA; CANDIDIASIS; FEMALE; HUMANS; INFANT, NEWBORN;

EID: 0029744457     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984;73:144-152.
2. Baley JE. Neonatal candidiasis: the current challenge. Clin perinatal 1991;18:263.
3. Weese-Mayer DE, Wheller Fondriest D, Broullette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987;6:190-196.
4. Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics. outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr 1990;116:791-797.
5. Heyman SN, Clark BA, Kaiser N y cols. In vivo and in vitro studies on the effect of amphotericin B on endothelin release. J Antimocrob Chemother 1992;29:69.
6. Janknegt R, De Marie S, Bakker-Woudenberg IAJM, Crommelin DJA. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinetic 1992;23:279-291.
7. Proffitt R, Satorius A, Chiang S, Sullivan L, Adler-Moore J. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991;28(Suppl B):49-61.
8. Adler-Moore JP, Proffitt RT. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 1993;3:429-450.
9. Adler-Moore JP, Fujii G, Lee MJA y cols. In vitro and in vivo interactions of AmBisome with pathogenic fungi J Liposome Res 1993;3:151-156.
10. Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991;10:665-668.
11. Tollemar J, Ringden O, Tyden G. Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin Transplant 1990;4:167-175.
12. Ringden O, Meunier F, Tollemar J y cols. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromissed patients. J Antimicrob Chemother 1991;28(Suppl B):73-82.
13. Zoubek A, Emminger W, Emminger-Schmidmeier W y cols. Conventional vs. Liposomal Amphotericin B in immunosupresed children. Pediatr Hematol Oncol 1992;9:187-190.
14. Ringden O, Tollemar J. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children. Mycoses 1993;36:187-192.
15. Lackner H, Schwinger W, Urban C y cols. Liposomal amphotericin B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 1992;89:1249-1261.
16. Pereira da Silva L, Videira Amara JM, Cordeiro Ferreira N. Which Is de Most Appropiate Dosage of Liposomal Amphotericin B (AmBisome) for the Treatment of Fungal Infections in Infants of Very Low Birth Weight?. (Letter). Pediatrics 1993;6:1217-1218.
17. Houmeau L, Monfort-Gouraud M, Boccara JF, Badoual J. Méningite à Candida, chez un prématuré, traité par amphotéricine B liposomale et flucytosine. Arch Fr Pediatr 1993;50:227-230.
18. Sievers R, Neubauer AP, Natzschka J. Therapie mit liposomalem Amphotericin B bei neonataler Pilzepsis mit enzephalitischer und osteoarthritischer Beteiligung. Monatsschr Kinderheilkd 1994;142:266-268.
19. Leibovitz E, Iuster-Reicher A, Armitai M, Mogilner B. Systemic Candidal Infections Associated with Use of Peripheral Venous Catheter in Neonates: A 9-Year Experience. Clin Infect Dis 1992;14:485-491.
20. Faix RG. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 1992;11:88-93.